Abstract

In February and March 2020, two mass swab testing campaigns were conducted in Vo’, Italy. In May 2020, we tested 86% of the Vo’ population with three immuno-assays detecting antibodies against the spike and nucleocapsid antigens, a neutralisation assay and Polymerase Chain Reaction (PCR). Subjects testing positive to PCR in February/March or a serological assay in May were tested again in November. Here we report on the results of the analysis of the May and November surveys. We estimate a seroprevalence of 3.5% (95% Credible Interval (CrI): 2.8–4.3%) in May. In November, 98.8% (95% Confidence Interval (CI): 93.7–100.0%) of sera which tested positive in May still reacted against at least one antigen; 18.6% (95% CI: 11.0–28.5%) showed an increase of antibody or neutralisation reactivity from May. Analysis of the serostatus of the members of 1,118 households indicates a 26.0% (95% CrI: 17.2–36.9%) Susceptible-Infectious Transmission Probability. Contact tracing had limited impact on epidemic suppression.

Vo’, Italy, is a unique setting for studying SARS-CoV-2 antibody dynamics because mass testing was conducted there early in the pandemic. Here, the authors perform two follow-up serological surveys and estimate seroprevalence, the extent of within-household transmission, and the impact of contact tracing.

Details

Title
SARS-CoV-2 antibody dynamics and transmission from community-wide serological testing in the Italian municipality of Vo’
Author
Dorigatti Ilaria 1   VIAFID ORCID Logo  ; Lavezzo Enrico 2   VIAFID ORCID Logo  ; Manuto Laura 2 ; Ciavarella Constanze 1   VIAFID ORCID Logo  ; Pacenti Monia 3 ; Boldrin Caterina 3 ; Cattai Margherita 3 ; Saluzzo Francesca 2   VIAFID ORCID Logo  ; Franchin Elisa 2 ; Del Vecchio Claudia 2 ; Caldart Federico 2   VIAFID ORCID Logo  ; Castelli Gioele 2   VIAFID ORCID Logo  ; Nicoletti, Michele 2   VIAFID ORCID Logo  ; Nieddu Eleonora 2 ; Salvadoretti Elisa 2 ; Labella Beatrice 2 ; Fava Ludovico 2 ; Guglielmo, Simone 2   VIAFID ORCID Logo  ; Fascina Mariateresa 2 ; Grazioli, Marco 2 ; Alvisi Gualtiero 2 ; Vanuzzo Maria Cristina 3 ; Zupo Tiziano 3 ; Reginetta, Calandrin 3 ; Lisi Vittoria 3 ; Rossi, Lucia 3 ; Castagliuolo Ignazio 2 ; Merigliano Stefano 4   VIAFID ORCID Logo  ; Unwin H Juliette T 1   VIAFID ORCID Logo  ; Plebani, Mario 5 ; Padoan, Andrea 5 ; Brazzale, Alessandra R 6 ; Toppo Stefano 7 ; Ferguson, Neil M 1   VIAFID ORCID Logo  ; Donnelly, Christl A 8   VIAFID ORCID Logo  ; Crisanti, Andrea 9 

 Imperial College London, MRC Centre for Global Infectious Disease Analysis and the Abdul Latif Jameel Institute for Disease and Emergency Analytics, School of Public Health, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111) 
 University of Padova, Department of Molecular Medicine, Padova, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470) 
 Azienda Ospedale Padova, Padova, Italy (GRID:grid.411474.3) (ISNI:0000 0004 1760 2630) 
 University of Padova, Department of Surgery, Oncology and Gastroenterology, Padova, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470) 
 University of Padova, Department of Medicine, Padova, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470) 
 University of Padova, Department of Statistical Sciences, Padova, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470) 
 University of Padova, Department of Molecular Medicine, Padova, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470); University of Padova, CRIBI Biotech Centre, Padova, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470) 
 Imperial College London, MRC Centre for Global Infectious Disease Analysis and the Abdul Latif Jameel Institute for Disease and Emergency Analytics, School of Public Health, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111); University of Oxford, Department of Statistics, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948) 
 University of Padova, Department of Molecular Medicine, Padova, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470); Azienda Ospedale Padova, Padova, Italy (GRID:grid.411474.3) (ISNI:0000 0004 1760 2630); Department of Life Science Imperial College London, Exhibition Road, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2553124440
Copyright
© The Author(s) 2021. corrected publication 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.